Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

BAKERHOSTETLER ADDS INTERNATIONAL LAWYER TO GROWING ANDA PRACTICE

BAKERHOSTETLER ADDS INTERNATIONAL LAWYER TO GROWING ANDA PRACTICE

Biologics and pharmaceutical litigator Irene Hudson strengthens IP Group

BakerHostetler today announced that biologics and pharmaceutical litigator Irene Hudson has joined the Intellectual Property Group and the Biotechnology, Chemical and Pharmaceutical team, resident in the New York office as partner. Hudson comes to BakerHostetler from Fish & Richardson.

Hudson will concentrate her practice on representing domestic and international biologics, pharmaceutical and medical device companies on complex patent infringement litigation, with a particular focus on Hatch-Waxman-based litigation. With a background in pharmacy, Hudson draws on her knowledge of the Food and Drug Administration’s (FDA’s) regulations and statutes concerning New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), Biologics License Applications (BLAs), new drug product exclusivity, and the Hatch-Waxman and Biologics Price Competition and Innovation Act to devise strategies to guide clients through exclusivity rights and challenges involving litigation, arbitration, or mediation.

As part of BakerHostetler’s ongoing strategic expansion in this practice area, Hudson joins other recent additions, Partner Ben Hsing and Counsel Wanda French-Brown. With one of the nation’s largest IP practices, the firm has more than 170 dedicated IP lawyers, with over 100 lawyers and patent agents registered to practice before the U.S. Patent and Trademark Office. “Over the past year, BakerHostetler has focused on building a comprehensive ANDA practice to service our growing roster of clients in the pharmaceutical industry,” said John Weber, Chair of the Intellectual Property Group. “Irene’s extensive experience, particularly working with pharmaceutical and medical device companies, continues to enhance the firm’s specialized skills in this practice area.”

Representing Fortune 500 companies, large corporations, and emerging pharmaceutical companies through all stages of trial preparation for patent violation actions, Hudson is an effective advisor through discovery and depositions, claim construction, summary judgment motions, and pretrial and trial proceedings before judges and juries in various federal district courts. She has represented clients in multipatent and multidefendant cases across international borders involving several countries. In addition, she has managed worldwide trademark portfolios and directed trademark and trade dress litigations.

“BakerHostetler knows that pharmaceutical clients require highly skilled practitioners like Ben, Wanda, and now Irene – attorneys who understand the law and its intersection within specific technologies, as well as the industry trends occurring in a changing global marketplace,” said David Sheehan, Intellectual Property Coordinator for the New York office. “Irene is versed in all facets of specialized litigation as it relates to biologics, pharmaceuticals and medical devices and will round out this immensely talented team.”

“We’re thrilled that Irene is joining us in the New York office,” said George Stamboulidis, Managing Partner of BakerHostetler’s New York office. “Her skills enhance a robust team of attorneys focused on ANDA litigation and other IP-related matters across the country.”

“BakerHostetler has a deep bench of intellectual property attorneys who practice across a multitude of life sciences disciplines,” said Hudson. “These synergies generated from the group’s broad industry reach align perfectly with the needs of my clients.”

Hudson is a frequent speaker and presenter on patent litigation, licensing and litigation. She received her J.D. from Hofstra University School of Law in 2002, and earned her B.S. in pharmacy from St. John’s University in 1999.

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post